Fintel reports that on January 21, 2026, RBC Capital upgraded their outlook for Biohaven (NYSE:BHVN) from Sector Perform to ...

Fintel reports that on January 21, 2026, Barclays upgraded their outlook for Alliant Energy (NasdaqGS:LNT) from Underweight to Equal-Weight. Analyst Price Forecast Suggests 9.75% Upside As of January ...

As of September 30, 2025, Janus Henderson had approximately US$484 billion in assets under management, more than 2,000 employees, and offices in 25 cities worldwide. The firm helps millions of people ...

The Portfolio returned 6.27% (gross) and the MSCI All Country World ex USA Index SM returned 7.03%. Non-U.S. stocks rose strongly on market relief at a de-escalation of the trade war. Shares of ...

The Portfolio returned 3.60% (gross) and the Russell Midcap® Value Index returned 6.18%. Equity markets rose over the quarter, on positive corporate earnings, increased expectations for Federal ...

Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people ...

Janus Henderson Investors' Pat Sanderson on why his focus this year will be on tech, smaller companies, fixed income... and ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Capital Markets industry for Tuesday, January 13, 2026. Let’s ...

Real estate investment trust Healthpeak Properties has formed another REIT, Janus Living, which will serve as the manager of its 34-community, 10,422-unit senior housing portfolio, Healthpeak ...

Cancer drugs are always popular biotech investments, but autoimmune disease also figures prominently in the startup ...

Trian and General Catalyst said going private will free the firm “from the constraints of operating as a public company.” ...

The Cambridge, Massachusetts-based company – known as FogPharma until a rebrand in 2024 – needs cash for pivotal trials of ...